Literature DB >> 16210570

Upregulation of proinflammatory proteins through NF-kappaB pathway by shed membrane microparticles results in vascular hyporeactivity.

Angela Tesse1, M Carmen Martínez, Bénédicte Hugel, Karel Chalupsky, Christian D Muller, Ferhat Meziani, Delia Mitolo-Chieppa, Jean-Marie Freyssinet, Ramaroson Andriantsitohaina.   

Abstract

OBJECTIVE: Microparticles are membrane vesicles with procoagulant and proinflammatory properties released during cell activation, including apoptosis. The present study was designed in dissecting the effects evoked by microparticles on vascular reactivity. METHODS AND
RESULTS: Microparticles from either apoptotic T lymphocytic cells or from plasma of diabetic patients with vascular complications induced vascular hyporeactivity in response to vasoconstrictor agents in mouse aorta. Hyporeactivity was reversed by nitric oxide (NO) synthase plus cyclooxygenase-2 inhibitors, and associated with an increased production of vasodilatory products such as NO and prostacyclin. Microparticles induced an upregulation of proinflammatory protein expressions, inducible NO-synthase and cyclooxygenase-2, mainly in the medial layer of the vessels as evidenced by immunochemical staining. In addition, microparticles evoke NF-kappaB activation probably through the interaction with the Fas/Fas Ligand pathway. Finally, in vivo treatment of mice with lymphocyte-derived MPs induces vascular hyporeactivity, which was reversed by the combination of NO and cyclooxygenase-2 inhibitors.
CONCLUSIONS: These data provide a rationale to explain the paracrine role of microparticles as vectors of transcellular exchange of message in promoting vascular dysfunction during inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210570     DOI: 10.1161/01.ATV.0000189298.62240.5d

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  20 in total

Review 1.  Microparticles as mediators and biomarkers of rheumatic disease.

Authors:  David S Pisetsky; Anirudh J Ullal; Julie Gauley; Tony C Ning
Journal:  Rheumatology (Oxford)       Date:  2012-03-07       Impact factor: 7.580

2.  Interception of the endotoxin-induced arterial hyporeactivity to vasoconstrictors.

Authors:  Shuang Zhang; Ningren Cui; Shanshan Li; Lei Guo; Yang Wu; Daling Zhu; Chun Jiang
Journal:  Vascul Pharmacol       Date:  2014-04-30       Impact factor: 5.773

3.  Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility.

Authors:  Ferhat Meziani; Angela Tesse; Eric David; M Carmen Martinez; Rosemarie Wangesteen; Francis Schneider; Ramaroson Andriantsitohaina
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 4.  Microvesicles at the crossroads between infection and cardiovascular diseases.

Authors:  Jing Xiong; Virginia M Miller; Yunman Li; Muthuvel Jayachandran
Journal:  J Cardiovasc Pharmacol       Date:  2012-02       Impact factor: 3.105

Review 5.  The role of microparticles in the pathogenesis of rheumatic diseases.

Authors:  Christian Beyer; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2009-12-01       Impact factor: 20.543

6.  Large Extracellular Vesicle-Associated Rap1 Accumulates in Atherosclerotic Plaques, Correlates With Vascular Risks and Is Involved in Atherosclerosis.

Authors:  Liliana Perdomo; Xavier Vidal-Gómez; Raffaella Soleti; Luisa Vergori; Lucie Duluc; Maggy Chwastyniak; Malik Bisserier; Soazig Le Lay; Alexandre Villard; Gilles Simard; Olivier Meilhac; Frank Lezoualc'h; Ilya Khantalin; Reuben Veerapen; Séverine Dubois; Jérôme Boursier; Samir Henni; Frédéric Gagnadoux; Florence Pinet; Ramaroson Andriantsitohaina; M Carmen Martínez
Journal:  Circ Res       Date:  2020-06-16       Impact factor: 17.367

7.  Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation.

Authors:  Tomohiro Itoh; Yuko Ito; Yoshinori Ohtsuki; Masashi Ando; Yasuyuki Tsukamasa; Nami Yamada; Tomoki Naoe; Yukihiro Akao
Journal:  J Mol Histol       Date:  2012-04-17       Impact factor: 2.611

Review 8.  Bench-to-bedside review: circulating microparticles--a new player in sepsis?

Authors:  Ferhat Meziani; Xavier Delabranche; Pierre Asfar; Florence Toti
Journal:  Crit Care       Date:  2010-10-20       Impact factor: 9.097

9.  Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-ligand pathway in mice.

Authors:  Abdelali Agouni; Pierre-Henri Ducluzeau; Tarek Benameur; Sébastien Faure; Martina Sladkova; Lucie Duluc; Georges Leftheriotis; Olga Pechanova; Mirela Delibegovic; Maria Carmen Martinez; Ramaroson Andriantsitohaina
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

10.  Microparticles as immune regulators in infectious disease - an opinion.

Authors:  Zheng Lung Ling; Valery Combes; Georges E Grau; Nicholas J C King
Journal:  Front Immunol       Date:  2011-11-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.